What happened with CNC today?
No read yet
Uses news and trading volume to explain the day’s move and how it relates to the market.
Stop guessing. Get the call, a three-month target price, the best and worst cases, and a source for every claim.
Centene insures people’s healthcare costs and pays hospitals, doctors and other providers for covered care. Medicaid, the government healthcare program for eligible low-income people, supplies most of its revenue. State programs pay Centene to cover members through its health plans; its Florida and New York contracts each account for a substantial share of Medicaid premiums.
Centene also sells individual and family coverage through the Affordable Care Act Marketplace under Ambetter Health, with federal tax credits helping eligible customers pay premiums. Its Medicare business provides health coverage and stand-alone Part D prescription drug insurance. The federal Centers for Medicare & Medicaid Services (CMS) pays monthly premiums for Medicare Advantage members and subsidizes Part D coverage, with government arrangements sharing some drug-cost risk.
Profitability depends on premiums covering members’ medical and drug costs plus operating expenses. Government funding, eligibility rules and contract renewals therefore matter, as do rates that reflect members’ health needs. Contracts can be lost if plans fail regulatory or performance standards, and Centene may have to return premiums when profits exceed permitted levels or too little premium income goes toward medical care.
The risk section is the longest, dullest part of the filing. This keeps only what can really hurt you: where it hits, how hard, when it plays out.
Every company claims an edge. Each one is checked against hard numbers like margins and returns: which hold, and which line gives way first.
Molina Healthcare and Centene compete for state Medicaid contracts and collect premiums to cover members’ care in Medicaid, Medicare and Marketplace plans, so both bear the risk of rising medical bills. Watch Molina’s Medicaid medical costs against payment-rate increases: Medicaid supplied 75% of its 2025 premium revenue, making that business a useful comparison for Centene’s cost pressure.
Elevance Health competes with Centene for Medicaid managed-care, Medicare Advantage and individual health-insurance members; both collect premiums in exchange for covering members’ medical costs.
Oscar Health and Centene’s Ambetter compete to insure individuals and families under the ACA, with enrollment and profits tied to premium subsidies and members’ health. Watch Oscar’s subsidized enrollment and medical costs as a comparison for Ambetter: in 2025, Oscar received 93% of its premiums directly from CMS through advance premium tax credits and 7% from members.
UnitedHealth Group’s UnitedHealthcare competes with Centene for Medicaid, Medicare Advantage and individual Marketplace insurance members, offering health coverage funded by government programs and individual premiums.
CVS Health’s Aetna competes with Centene in Medicaid managed care, Medicare Advantage and Medicare prescription-drug plans, providing coverage through government-sponsored plans and member premiums. Watch Aetna’s prescription-drug plan costs: the Part D changes that began in 2025 made Centene’s plans bear a larger share of drug-benefit costs.
Humana and Centene sell Medicare and state-sponsored health coverage, so government payment rates and members’ medical costs affect both insurers. Watch Humana’s Insurance segment rather than its CenterWell care-services business for a comparison with Centene’s government-funded coverage.
Centene relies on Cigna Group’s Express Scripts to manage customers’ prescription-drug benefits and provide access to a national retail pharmacy network under a multiyear agreement that began January 1, 2024. Watch Express Scripts’ drug-rebate negotiations and guarantees to clients for clues about pharmacy-benefit costs, without treating its broader client rebate terms as Centene’s contract terms.
Molina Healthcare, Inc. earningsMOH
Molina Healthcare’s report will show whether Medicaid medical costs are outpacing state payment rates, a comparison for Centene’s larger Medicaid business.
Watch how Molina Healthcare’s Medicaid medical costs compare with state payment-rate increases. If rates keep pace, premiums are better able to cover members’ care, a more favorable sign for Centene’s Medicaid pricing environment; if costs rise faster, similar pressure remains and Centene’s rates may not cover its medical spending. The companies serve different states and members, so this is a comparison, not a result for Centene.
Centene Corporation earningsThis company
Medical costs eat into the premiums Centene collects, and this report will show whether Medicaid and Marketplace premiums are keeping up.
Read the health benefits ratio—the share of premium revenue spent on medical care—alongside gross margins in Medicaid and Commercial. A falling ratio with stabilizing margins would show premiums covering more of the medical bills; a rising ratio and further margin declines would show costs still outrunning premiums and Centene’s pressure continuing.
CVS HEALTH CORPORATION earningsCVS
CVS Health’s report will show how prescription-drug costs are changing at Aetna, a comparison for Centene’s plans that also bear Part D drug-benefit costs.
Watch prescription-drug costs in CVS Health’s Aetna plans. If costs are contained, pressure on Part D drug benefits may be lighter, making it easier for Centene’s related plans to cover drug bills with premium revenue; if costs rise, drug spending may squeeze plan margins. Aetna’s plans differ from Centene’s, so this signals market pressure rather than proving Centene’s own results.
The Cigna Group earningsCI
Cigna Group’s Express Scripts manages drug benefits for Centene, and its report can show how rebate negotiations and client guarantees affect pharmacy-benefit costs.
Watch Express Scripts’ drug-rebate negotiations and guarantees to clients. If rebates or guarantees do more to offset drug spending, pharmacy-benefit management may provide a buffer against Centene’s related costs; if that offset weakens, Centene may face greater drug-cost pressure. Cigna Group’s terms with other clients are not Centene’s contract terms, so this is a supplier-side cost signal, not proof of Centene’s own costs.
Oscar Health, Inc. earningsOSCR
Oscar Health and Centene’s Ambetter both insure individuals and families in the ACA Marketplace, so Oscar’s report will show how subsidized enrollment and medical costs are changing.
Read Oscar Health’s subsidized enrollment together with its medical costs. Steady enrollment and contained costs would suggest Marketplace demand remains and premiums can better cover care, a more favorable market signal for Ambetter; weaker enrollment or costs rising relative to premiums would point to more pressure on Centene’s Marketplace revenue or margins. The companies have different member mixes, so this is not Ambetter’s actual result.
Humana Inc. earningsHUM
Humana’s report can show how medical costs compare with government payments in its Medicare insurance business, a comparison for Centene’s Medicare Advantage plans.
Look at Humana’s Insurance segment, not its CenterWell care-services business, and compare medical costs with government payments. If payments keep pace, Medicare insurance rates are better able to cover care, a more favorable signal for pricing Centene’s Medicare Advantage plans; if costs outrun payments, government-plan cost pressure remains high. Centene’s stand-alone prescription-drug business is larger, so Humana’s result does not represent all of Centene’s Medicare business.
